Medbright Ai Invts Inc.

MedBright AI Investments Inc. Announces Name Change and Amended Investment Policy

Algo8 Announces Successful Scaling of AI-Powered Process Optimization and Safety with a Global Automotive Component Manufacturer

MedBright AI Announces Termination of Limmi Agreements

MedBright AI Appointments Brandon Kou as Director

MedBright AI Announces the Appointment of Christopher Heath as CEO and Termination of Letter of Intent

MedBright AI Issues Clarifying News Release on Continuous Disclosure Record

MedBright AI Announces Strategic Acquisition by Numinus Wellness

Southern California Clinic Signs Multi-Year Deal for MedMatrix AI Platform

Southern California Clinic uses MedMatrix AI Market Expander to Launch Opening of New Clinic Locations

MedBright AI Announces Investor Relations Agreement with Anthem Strategies Ltd.

MedMatrix Go-to-Market Pricing Announced for AI Product Suite Addressing US$726 Billion Market

MedMatrix Product Moves from Beta to Full Commercialization, Announces AI Product Suite

MedBright AI Announces Limmi Disease Insights Platform Being Used in University Hospital Setting to Improve Detection of Kidney Stone Disease Recurrence

MedBright AI Announces Closing of LIFE Offering for Gross Proceeds of Approximately $1.4 Million

MedBright AI to Present at CEM Bahamas Small-Cap Conference and Maxim Group's 2024 Healthcare IT Conference

MedBright AI Reaches US$100M in Total Clinic Revenue Under Contract with MedMatrix, the AI-Powered Data Analytics Platform

MedBright AI Investments Inc. Responds to OTC Markets Request on Recent Promotional Activity

MedBright AI Announces Rejuvenation Medical Group, a Large Canadian Clinic Group, as First International Customer for MedMatrix, the AI-Driven Data and Analytics Platform

MedBright AI Announces Closing of Investment in Limmi Healthcare AI Platform

MedBright AI Announces CareMEDICA, a Yale University School of Medicine Affiliated Clinic Group, as Beta Customer for MedMatrix, the AI-Driven Data and Analytics Platform